IP Verse

Compositions For The Treatment Of Inflammation Of The Gastrointestinal Tract - EP2214677B1

PatentPatent Analysis

EP2214677

MERITAGE PHARMA
Application Number
EP08848917A
Filing Date
Nov 12, 2008
Status
Revoked
Dec 13, 2019
Grant Date
Aug 30, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3574914B1
EP2585075B8
EP3354276B1

Bibliography

The patent EP2214677B1 was granted to Meritage Pharma on Aug 30, 2017 following the initial filing on Nov 12, 2008 under the application number EP08848917A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DR FALK PHARMAMay 22, 2018 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents